In SARS-CoV-1 infection, DC/L-SIGN can enhance viral infection and dissemination [16,17] and even it has been proposed that L-SIGN could act as an alternative cell receptor to ACE2 [15]. Here, CLEC4M is linked to viral infectious disease.